News Announcement

Marksans Pharma: Re-Appointment Of Mr. Mark Saldanha For A Period Of 5 Years With Effect From 06-10-2025

The Board in its meeting considered the reappointment of Mr. Mark Saldanha for a period of 5 years with effect from 06-10-2025.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds